Miltefosine
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101668This classification denotes an alkylphosphocholine compound with the molecular formula C21H46NO4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 53EY29W7EC, chemically known as 3,5-dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-, hydroxide, inner salt, 4-oxide but generally known as miltefosine, which bears US NIH Compound Identifier 3599. European Medicines Agency schedules Miltefosine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08969MIG. The term MILTEFOSINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules miltefosine in its Anatomical Therapeutic Chemical (ATC) Classification. MILTEFOSINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule miltefosine under HS 29239000 and SITC 51481. As of Q4 2014, MILTEFOSINE remains the US FDA Preferred Term for this commodity. Miltefosine bears US NLM identifiers UMLS ID C0068006 and NCI Concept Code C1170. SMILES: P(=O)(OCC[N](C)(C)C)(OCCCCCCCCCCCCCCCC)O.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.